Accumulating studies indicate that chronic inflammation is considered an important driver of insulin resistance and type 2 diabetics (Hotamisligil, 2006), and IKK-NF-κB is one of the principal inflammatory pathways that disrupt insulin action (Cai et al., 2005). This evidence concerns the gene NFKB1 and Insulin resistance.